AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Iowa

HF2085

A bill for an act relating to the production and administration of psilocybin and providing penalties.

Status

Pending

2026 Session

IntroducedJan 15, 2026 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Sponsor: John Wills (Republican)
Type: Therapeutic Access
Substances: Psilocybin

Official text

Summary (from PoliPsy)

A bill for an act relating to the production and administration of psilocybin and providing penalties.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: legis.iowa.gov

Legislative history

January 26, 2026
Subcommittee Meeting: 01/26/2026 12:15PM RM 305 (Cancelled).
January 15, 2026
Referred
January 15, 2026
Introduced

Loading bill…